CD274 and neoplasm: Previously identified features associated with ICI response include tumor mutation burden (TMB)10, neoantigen burden11,12, expression of antigen presentation machinery13,14, DNA damage response (DDR) pathway mutations15,16, PD-L1 expression11,17, IFNγ signature18, intratumoral heterogeneity19,20, and microbiota features21,22.